UCB SA - Company Profile
Powered by 
All the sales intelligence you need on UCB SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how UCB SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with UCB SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View more- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
The following section provides information on UCB SA’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into UCB SA's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Jonathan Peacock
Chairman Executive BoardMr. Jonathan Peacock has been the Chairman of the company since March 2023. He serves as a Director of the company since 2021. Prior to this, he served as the Chairman and Chief Executive Officer of Bellerophon Therapeutics Inc. Previously, he served as the Chairman of Arix Bioscience Plc from 2016-2020.
Jean-Christophe Tellier
Director; Chief Executive Officer Executive BoardMr. Jean-Christophe Tellier has been the Chief Executive Officer and Director of the company since 2014. Prior to this, he served as the Executive Vice President of BioBrands and Solutions division of the company. Currently, he also serves as the Member of the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Vice Chairman of the Innovation Board Sponsored Committee (EFPIA), President of International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Chairman of the BCR.
Sandrine Dufour
Chief Financial Officer; Executive Vice President Senior ManagementMs. Sandrine Dufour has been the Executive Vice President and Chief Financial Officer of the company since 2020. Prior to this, she served as the Chief Financial Officer of Proximus. Previously, she served as the Executive Vice President of Innovation and Deputy Chief Financial Officer of Vivendi. Ms. Dufour also served as the Executive Vice President of Finance and Strategy at SFR.
Alistair Henry
Executive Vice President; Chief Scientific Officer Senior ManagementMr. Alistair Henry has been the Executive Vice President and Chief Scientific Officer of the company since May 2024. Prior to this, he served as the Head of UK Research operation of the company.
Jean-Luc Fleurial
Executive Vice President; Chief Human Resources Officer Senior ManagementMr. Jean-Luc Fleurial has been the Executive Vice President and Chief Human Resource Officer of the company since 2017. Prior to this, he served as the Vice President, Human Resources, US Commercial, World Wide Commercialization, Policy and Operations at Bristol-Myers Squibb. Mr. Fleurial also held various leading positions in Procter & Gamble in Europe.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer